Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Parker-Hannifin
PH
|
$296M |
| 2 |
Microsoft
MSFT
|
$279M |
| 3 |
Union Pacific
UNP
|
$267M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
$259M |
| 5 |
McDonald's
MCD
|
$254M |
Top Sells
| 1 |
Medtronic
MDT
|
$592M |
| 2 |
Apple
AAPL
|
$523M |
| 3 |
Amgen
AMGN
|
$457M |
| 4 |
General Dynamics
GD
|
$401M |
| 5 |
CSX Corp
CSX
|
$338M |
Sector Composition
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.93% |
| 4 | Industrials | 13.17% |
| 5 | Consumer Discretionary | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
T Rowe Price
TROW
$23.8B
| $144M | 0.08% |
1,334,550
+1,028,737
| +336% | +$111M |
|
277
Ligand Pharmaceuticals
LGND
$3.25B
| $144M | 0.08% |
1,397,994
-67,765
| -5% | -$6.98M |
|
278
eBay
EBAY
$42.3B
| $144M | 0.08% |
3,568,732
-279,779
| -7% | -$11.3M |
|
279
Insmed
INSM
$30.7B
| $141M | 0.08% |
6,246,342
+283,136
| +5% | +$6.38M |
|
280
Jazz Pharmaceuticals
JAZZ
$7.86B
| $140M | 0.08% |
928,107
-1,927
| -0.2% | -$291K |
|
281
ITT
ITT
$13.3B
| $140M | 0.08% |
2,858,847
-93,823
| -3% | -$4.6M |
|
282
Western Digital
WDC
$31.9B
| $140M | 0.08% |
2,006,498
-1,369,029
| -41% | -$95.5M |
|
283
Verizon
VZ
$187B
| $140M | 0.08% |
2,917,450
-37,083
| -1% | -$1.77M |
|
284
D.R. Horton
DHI
$54.2B
| $139M | 0.08% |
3,174,086
+2,040,605
| +180% | +$89.5M |
|
285
American Electric Power
AEP
$57.8B
| $139M | 0.08% |
2,025,978
+281,649
| +16% | +$19.3M |
|
286
Vertex Pharmaceuticals
VRTX
$102B
| $139M | 0.08% |
852,241
-319,130
| -27% | -$52M |
|
287
Scotiabank
BNS
$78.8B
| $138M | 0.08% |
+2,245,395
| New | +$138M |
|
288
Globus Medical
GMED
$8.18B
| $138M | 0.08% |
2,764,845
-712,060
| -20% | -$35.5M |
|
|
ETFC
289
DELISTED
E*Trade Financial Corporation
ETFC
| $137M | 0.08% |
2,472,298
-12,961
| -0.5% | -$718K |
|
290
LKQ Corp
LKQ
$8.33B
| $137M | 0.08% |
3,604,129
+645,824
| +22% | +$24.5M |
|
291
Corning
GLW
$61B
| $136M | 0.08% |
4,882,276
-412,969
| -8% | -$11.5M |
|
292
VF Corp
VFC
$5.86B
| $136M | 0.08% |
1,949,072
+1,125,080
| +137% | +$78.5M |
|
|
CALD
293
DELISTED
Callidus Software, Inc.
CALD
| $135M | 0.08% |
3,768,920
-257,752
| -6% | -$9.27M |
|
294
Axon Enterprise
AXON
$57.2B
| $135M | 0.08% |
3,439,753
-201,774
| -6% | -$7.93M |
|
295
Texas Roadhouse
TXRH
$11.2B
| $135M | 0.08% |
2,332,956
-71,419
| -3% | -$4.13M |
|
|
ABMD
296
DELISTED
Abiomed Inc
ABMD
| $134M | 0.08% |
460,829
-146,314
| -24% | -$42.6M |
|
|
KSU
297
DELISTED
Kansas City Southern
KSU
| $134M | 0.08% |
1,220,706
+303,806
| +33% | +$33.4M |
|
|
ALXN
298
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $134M | 0.08% |
1,201,429
-104,263
| -8% | -$11.6M |
|
299
Nordson
NDSN
$12.6B
| $133M | 0.08% |
978,322
+91,002
| +10% | +$12.4M |
|
300
Cedar Fair
FUN
$2.53B
| $133M | 0.08% |
2,084,325
-45,565
| -2% | -$2.91M |
|